Jidong Jia

57PUBLICATIONS
121CO-AUTHORS
PharmacogenomicsTraditional Chinese medicine and treatmentsNeural engineeringRespiratory diseasesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (57)

|Sep 18, 2026
A randomized, double-blind, active-controlled phase 3 multicenter trial of rHSA for cirrhotic ascites.

|May 29, 2026
Tolvaptan for hyponatremia in patients with cirrhosis: a post hoc subgroup analysis of a multicenter, randomized, double-blind, placebo-controlled trial.

|Nov 07, 2025
Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial.

Grace Lai-Hung Wong, Man-Fung Yuen, Bingliang Lin

|Oct 28, 2025
Unstable Recompensation: An Intermediate Subtype in Patients With HBV-Related Decompensated Cirrhosis.

Shuai Xia, Zhiying He, Xiaoning Wu

|Sep 23, 2025
Stage-Specific Transcriptome Landscape of Hepatocellular Carcinoma: Insights From Super and Poor Survivors With Prognostic Signature Identification.

Xiao Qian Xu, Hao Wang, Li Chen Shi

|Sep 12, 2025
Epidemiology, Achievements, and Challenges in the Elimination of Hepatitis B in China.

You Deng, Tongtong Meng, Hong You

Pageof 10

Frequent Collaborators

13 joint publications

Yuanyuan Kong

10 joint publications

Hong You

4 joint publications

Min Li

4 joint publications

Xinyan Zhao